Clinical Trial Update: A Phase 1,Open -Label Study to Assess the Absorption, Metabolism and Excretion of 14C-OPS-2071 Following a Single Oral Dose to Healthy Male Japanese Subjects [Phase 1]

View source ↗

Summary

This Phase 1 open-label PK study in healthy Japanese male subjects assessed absorption, metabolism, and excretion of a single oral dose of OPS-2071 (14C-labeled…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Enteritis

Drugs mentioned

• OPS-2071

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Bacterial Enteritis | Phase 1 | Status: COMPLETED | Results posted: 2016-08-24